Skip to main content
OpenTrials
Completed

NCT Number: NCT06418360

Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis

Objective: The aim of the present study was to investigate the treatment efficacy of TECAR therapy, a modern application that has been increasingly used in recent years, compared to conventional physical therapy applications in the treatment of knee osteoarthritis, according to the evaluation of the clinical findings of patients.

Methods: A total of 54 patients, aged between 40 and 75 years, were randomly divided into two groups. Both groups received CPT. Group 2 received TECAR therapy in addition to CPT, applied three times a week for two weeks, for a total of 6 sessions. All patient's knee joint range of motion (ROM) was measured goniometrically, isometric quadriceps muscle strength was measured, and pain levels were assessed using the Visual Analog Scale (VAS), and disability levels were assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) before treatment, at the end of treatment, at 1 month, and at 3 months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Knee Osteoarthritis Arthritis Energy Transfer Capacitative and Resistive Therapy Joint Diseases Musculoskeletal Diseases Osteoarthritis Osteoarthritis, Knee Rheumatic Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Özge TEZEN

Ankara, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 3 months of conservative treatment for unresponsive knee pain
  • Kellgren-Lawrence grade 2-3 on radiographic evaluation
  • Agreed to participate in the study.

Exclusion criteria

  • History of physical therapy (electrotherapy/exercise) in the past 3 months
  • Intra-articular injection therapy in the past 3 months,
  • History of surgery or trauma to the affected knee
  • Inflammatory or neurological disease affecting the lower extremities
  • Active vasculitis or severe peripheral vascular disease
  • Pregnancy or lactation
  • Diagnosed restless legs syndrome
  • Neoplasia
  • Local sensory impairment,
  • Local or systemic acute infections
  • Severe osteoporosis
  • Pacemaker
  • Psychiatric disorder and cognitive impairment.

Treatment and study plan

TECAR

Device

Transfer Energy Capacitative and Resistive Therapy

conventional physical therapy; Transcutaneous Electrical Nerve Stimulation, hotpack

Device

10 sessions of HP and TENS for two weeks, five times a week. HP was applied to the painful knee area for 20 minutes using a heating pad for superficial heating purposes. TENS was applied to the painful knee area for 20 minutes at 80 Hz frequency

Primary outcomes

  1. Visual Analog Scale (VAS)

    Time frame: Before and the after treatment 0th day , 1th month, 3rd month

    0 min , 10 is maximum pain score

  2. Western Ontario and McMaster Universities Arthritis Index (WOMAC)

    Time frame: Before and the after treatment 0th day, 1th month, 3rd month

    This 24-item index comprises three subscales: pain, stiffness, and physical function, each measured on a five-point Likert scale ranging from "none" to "extreme."

  3. Range of Motion (ROM)

    Time frame: Before and the after treatment 0th day, 1th month, 3rd month

    Flexion and extension of the knee joint were measured using a universal goniometer relative to reference points.

Secondary outcomes

  1. The Diers Myoline Isometric Muscle Strength Measurement System

    Time frame: Before and the end of treatment 0th day, 1th month, 3rd month

    quadriceps muscle Isometric Strength Measure: Increased isometric muscle strength is an indicator of recovery.

Sponsors and collaborators

Lead sponsor

Ankara City Hospital Bilkent

Other

Registry information

Official study title

Evaluation of The Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
May 17, 2024
Registry last updated
May 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.